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The CTX-M-1 group was found in 86.8% of the Escherichia coli isolates from Istanbul. A subset study
revealed all isolates carrying blaCTX-M-15 genes flanked by the insertion element ISEcp1. Plasmid typing of
transconjugates carrying blaCTX-M-15 showed that most isolates belonged to the Inc/rep FII group but that one
isolate also belonged to the FI group.
CTX-M-type enzymes were reported in Germany and Argen-
tina in 1989, and so far, more than 67 CTX-M-type -lactamases
have been identified, mostly in Escherichia coli, Klebsiella pneu-
moniae, and Salmonella enterica serovar Typhimurium isolates
(http://www.lahey.org). The global spread is now a major concern
in certain areas such as Latin America, Asia, Europe, Africa, and
North America (5).
Data on the prevalence and distribution of CTX-M-type
enzymes are very limited in Turkey. Two studies revealed that
CTX-M enzymes were present and disseminated among En-
terobacteriaceae family isolates in Turkey (1, 10). The aim of
this study was to determine the current prevalence of the
CTX-M-1 group and the molecular characteristics in E. coli
clinical isolates in a university hospital in Istanbul, Turkey.
(This work was presented in part as a poster at the “Mi-
crobes in a Changing World” Congress of the International
Union of Microbiological Societies (IUMS), San Francisco,
CA, 23 to 28 July 2005.)
A total of 1,010 consecutive nonrepetitive isolates of E. coli
obtained from inpatients and outpatients at the hospital of
Istanbul Faculty of Medicine over a 2-year period (2002 to
2004) were screened for extended-spectrum -lactamase
(ESBL) production, using the double-disc synergy test. A total
of 61 E. coli isolates (27 from inpatients and 34 from outpa-
tients) with ESBL phenotypes were included in this study, the
majority of which were from the urine and respiratory speci-
mens of patients treated in six different medical and surgical
wards.
MICs were determined by the agar dilution method. MICs
for cefotaxime, ceftriaxone, and ceftazidime used alone and in
combination were determined, with 4 g/ml clavulanic acid for
phenotypic detection of ESBLs.
Conjugation experiments for the transfer of cefotaxime re-
sistance were carried out with all CTX-M-1-producing E. coli
isolates (8). Crude extracts of -lactamases were subjected to
isoelectric focusing (IEF) (3).
All isolates were screened for the CTX-M-1 group (13) and
blaTEM (16) and blaSHV (9). Strains which had pI bands at 7.3
were subjected to blaOXA-1-like PCR using the primers OXA-
1-A (5-GAATCGCATTATCACTTATGG-3) and OXA-1-B
(5-GATACATGTTCTCTATGG-3; this study). PCR ampli-
cons for linking ISEcp1 with blaCTX-M were obtained by anchor-
ing one primer at the 3 end of blaCTX-M (blaCTX-M reverse,
5CACTTTGTCGTCTAAGGCG3) and the other to the 5 end
of ISEcp1 (5AATACTACCTTGGCTTTCTGA3).
Sequencing was carried out with both strands by using the
dideoxy chain termination method with a Perkin Elmer Bio-
systems 377 DNA sequencer. Sequence analysis was per-
formed using a Lasergene DNASTAR software package. Se-
quence alignments were done using Clustal W software and a
PAM 250 matrix.
After isoelectric focusing was carried out, a bioassay was
assigned to visualize and confirm the hydrolytic activity of the
enzymes detected by the isoelectric focusing (4).
Randomly amplified polymorphic DNA (RAPD) analyses
were performed using an ERIC2 primer (7).
A subset of E. coli isolates had their plasmids fully charac-
terized. Plasmids were isolated by the alkaline lysis method
(12) and used to transform E. coli TOPO cells (Invitrogen,
Paisley, United Kingdom) via electroporation. Transformants
were checked by PCR for carriage of the CTX-M type 1 gene.
Plasmids were restricted using EcoR1, their sizes were assessed
(2), and they were typed according to the method described by
Carattoli et al. (6). Initially, multiplex PCR was used and then
refined, with single PCR used to obtain clear amplicons for
sequencing.
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TABLE 1. MICs, isoelectric points, PCR results, and sequence and plasmid analyses for ESBL-positive E. coli isolates
Isolate
MIC (g/ml) (drug
sensitivity)a pI value
PCR or sequencing resultb RAPD
PCR
resultc
Result of
conjugation
of CTX-M-15d
blaCTX-M-15
Inc typee
CTX CAZ blaTEM blaSHV blaCTX-M-15 OXA-1-like
1 128 (R) 16 (I) 8.6    a  FI
2 16 (I) 4 (S) 5.6 8.4    b 
3 128 (R) 64 (R) 5.6 8.5    b
4 128 (R) 64 (R) 5.6 8.4    c  FII
5 64 (R) 8 (S) 8.4    a  ND
6 32 (I) 8 (S) 5.6 8.4    d  FII
7 128 (R) 64 (R) 5.4 8.4    
8 32 (I) 4 (S) 7.4 8.4    e  ND
9 128 (R) 64 (R) 5.4 7.3 8.4     c  FII
10 256 (R) 64 (R) 5.4 7.3 8.4     f  FII
11 128 (R) 64 (R) 5.4 7.3 8.6     b  FII
12 128 (R) 16 (I) 5.4 7.2 8    a 
13 128 (R) 64 (R) 5.4 7.3 8.4     g  FII
14 128 (R) 64 (R) 5.4 7.3 8.4     g  FII
15 32 (I) 64 (R) 5.4 7.3 8.6     b  FII
16 256 (R) 64 (R) 7.3 8.6     a 
17 512 (R) 256 (R) 6.2 7.3 8.4     h 
18 128 (R) 128 (R) 5.4 8.6    i  FII
19 256 (R) 64 (R) 5.4 8.6    i  FII
20 32 (I) 8 (S) 5.4 8.4    b 
21 64 (R) 128 (R) 7.3 8.4     j 
22 32 (I) 4 (S) 5.4 8.4    k  ND
23 256 (R) 64 (R) 5.4 7.3 8.6     g  FII
24 128 (R) 32 (R) 5.4 7.3 8.6     g  FII
25 128 (R) 32 (R) 5.6 7.3 8.6     g 
26 256 (R) 128 (R) 5.6 7.3 8.6     g  FII
27 256 (R) 64 (R) 5.6 8.4    b  ND
28 256 (R) 64 (R) 8.6    a 
29 512 (R) 128 (R) 5.6 7.3 8.4     e  ND
30 128 (R) 32 (R) 5.6 7.4 8.4    l  ND
31 256 (R) 32 (R) 7.3 8.6     l  FII
32 256 (R) 32 (R) 5.4 7.3 8.6     m  FII
33 8 (S) 2 (S) 5.4 8.4 8.9    e 
34 512 (R) 128 (R) 5.4 7.3 8.9     b  ND
35 128 (R) 8 (S) 5.4 7.2 8.9    a 
36 64 (R) 64 (R) 5.4 8.4    l 
37 256 (R) 8 (S) 5.4 8.4    b 
38 128 (R) 64 (R) 8.9    k  ND
39 64 (R) 256 (R) 5.4 8.4    l  FII
40 512 (R) 256 (R) 7.3 8.9     a 
41 32 (I) 8 (S) 8.4    a 
42 128 (R) 64 (R) 7.3 7.6     l 
43 128 (R) 256 (R) 5.2    g
44 16 (I) 4 (S) 5.4 8.4    l 
45 256 (R) 128 (R) 5.2 7.3     l
46 64 (R) 8 (S) 7.3 8     b
47 128 (R) 128 (R) 7.3 7.6     l  ND
48 2 (S) 16 (I) 7    b
49 256 (R) 64 (R) 5.2    l
50 128 (R) 256 (R) 5.4 8.6    l  FII
51 128 (R) 32 (R) 5.4 7.3 7.6     l
52 32 (I) 16 (I) 5.4 8.4    b  ND
53 32 (I) 64 (R) 6.4 6.8 7    b
54 256 (R) 256 (R) IBf IB IB    l 
55 32 (I) 16 (I) IB IB IB    k 
56 512 (R) 512 (R) 8    l  ND
57 256 (R) 512 (R) 5.4 7.2 8.4    b
58 256 (R) 128 (R) 5.4 7.3 8.9     
59 256 (R) 128 (R) 5.4 8.9    b 
60 512 (R) 128 (R) 7.3 8.9     a 
61 256 (R) 64 (R) 5.4 7.3 8.9     l 
a CTX, cefotaxime; CAZ, ceftazidime; I, insensitivity; R, resistance; S, sensitivity.
b Sequencing was carried out with blaCTX-M amplicons only to confirm the identification as blaCTX-M-15.
c Lowercase letters represent the different clones of E. coli isolates.
d Where there is no plus or minus given, the blaCTX-M-15 gene has not been detected.
e Plasmid typing was carried out with transconjugates from selected isolates based on RAPD typing and phenotypic characteristics. ND, indicates where blaCTX-M-15
genes were detected from transconjugates but the plasmids remained uncharacterized.
f IB, indefinite bands.
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Sixty-one (6%) out of the 1,010 E. coli isolates were found to
be positive for the presence of ESBLs, in our study. There was
a high rate of resistance against ciprofloxacin (80.4%). The
most active antibiotics for ESBL-producing E. coli were ami-
kacin (91.9%) and imipenem (100%).
The pI values of the -lactamases and the PCR results for
ESBL-encoding genes are shown in Table 1. All of the CTX-
M-1-group-positive E. coli isolates were confirmed to possess
cefotaxime-hydrolyzing activity in the subsequent bioassay ex-
periments, corroborating the pI values with cefotaximase ac-
tivity. Positive amplicons were sequenced, and all were shown
to be blaCTX-M-15. As blaCTX-M-15 is ubiquitously associated
with ISEcp1 (13, 14), the genetic context was sought by using
the PCR strategy described previously. In all CTX-M-15-pos-
itive isolates, blaCTX-M-15 was found directly adjacent to the
ISEcp1.
The results of RAPD analyses indicated that there was no
evidence for the spread of a single bacterial clone responsible
for the high prevalence of CTX-M-15 isolates. Conjugation
experiments were performed with all 53 CTX-M-1 group
ESBL-producing E. coli strains, to examine the rate of transfer.
Transconjugants were obtained for 29 isolates (Table 1). The
high conjugation efficiency of about 103 to 104 recombinants
per donor cell (E. coli K-12 W3110 Rifr Lac) was observed, and
all transconjugants expressed the ESBL-related resistance phe-
notypes.
Plasmid analysis indicated that in all cases, the strains pos-
sessed more than one plasmid, with some strains possessing up
to five. The presence of the blaCTX-M-15 genes in cefotaxime-
resistant transconjugates were confirmed by PCR and sequenc-
ing. Once transconjugates were confirmed, they were randomly
selected, and plasmids were isolated as described previously.
Multiplex PCR was undertaken to determine the plasmid Inc/
rep type, followed by simplex PCR as previously described (6,
11). In one isolate (Table 1, isolate 1), the blaCTX-M-15 gene
was carried on a plasmid of approximately 65 kb and possessed
an F1 Inc/rep type. The other plasmids (n  17) that were
typed possessed a large plasmid of approximately 140 kb,
which possessed an Inc/rep type of FII (Table 1).
Data show that the isolation of the CTX-M-1-group-positive
E. coli accounted for 86.8% of the ESBL-positive E. coli iso-
lates. The abundance of different phenotypes and the presence
of multiple different enzymes in each strain indicate that the
epidemiology of ESBLs in our hospital is complex. The high
clinical incidence of blaCTX-M-15 since 2004 suggests that the
gene pool was well established prior to this date. Interestingly,
the transconjugates demonstrating blaCTX-M-15 carriage were
predominantly Inc/rep type FII but also type FI, and while the
FII and blaCTX-M-15 relationship is well established, this is not
the case with FI (11, 15).
The high prevalence of the CTX-M-15 group underlines the
need for further surveillance and further investigation for bet-
ter understanding of the epidemiology and the genetic back-
ground of this specific resistance trend, but the present results
demonstrate that CTX-M-15 has emerged and spread in a very
short period in our hospital.
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